첨단 상처 치료 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문 예측(2026-2033년)

Advanced Wound Care Market Summary

The global advanced wound care market size was estimated at USD 11.7 billion in 2025 and is projected to reach USD 17.8 billion by 2033, growing at a CAGR of 5.44% from 2026 to 2033. The increasing number of surgeries, the augmenting number of road accidents, trauma cases & burns, and the introduction of innovative & advanced wound products are some of the factors driving market growth.

Additionally, the increasing prevalence of chronic diseases that impair wound healing capabilities further enhances the demand for advanced wound products. Moreover, the growing geriatric population is expected to propel market growth, as the geriatric population has slow healing capabilities. For instance, in March 2024, the Albanese Government revealed funding of more than $3 million for new initiatives aimed at addressing the hidden epidemic of chronic wounds in Australia. It is estimated that around 450,000 Australians are currently living with chronic wounds.

According to the United Nations Population Fund's India Ageing Report 2023, the population over 60 is likely to increase from 14.9 crores in 2022 to 34.7 crores by 2050, which is expected to propel market growth. People with diabetic foot ulcers (DFU) are at a high risk of lower-extremity amputation. As per a ScienceDirect article, diabetic foot ulcers may affect more than 25.0% of the diabetic population and may result in amputation in 20.0% of patients. However, advanced wound care products help cure diabetic foot ulcers, which are prevalent in diabetic patients. Thus, an increasing number of diabetic patients is expected to elevate the use of advanced wound care products. These products especially help in moisture retention and facilitate rapid internal and external wound healing. Furthermore, these products help in the absorption of necrotic tissues, which are effective in surgical site infections. Hence, healthcare professionals prefer to use advanced wound care products, which is anticipated to propel global wound care industry growth over the forecast period.

However, the market experienced lucrative growth post-pandemic. Many companies underwent new product launches and mergers and acquisitions, further increasing their product portfolio. For instance, in September 2024, HCAH, a provider of out-of-hospital healthcare solutions in India, partnered with Aroa Biosurgery to launch a new initiative aimed at improving patient outcomes. This collaboration will leverage Aroa Biosurgery's innovative wound care technologies and HCAH's extensive network to enhance patient care and accelerate healing processes.

Global Advanced Wound Care Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global advanced wound care market report based on product, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Moist
  • Foam Dressings
  • Hydrocolloid Dressings
  • Film Dressings
  • Alginate Dressings
  • Hydrogel Dressings
  • Collagen Dressings
  • Other Advanced Dressings
• Antimicrobial
  • Silver
  • Non-silver
• Active
  • Biomaterials
  • Skin-substitute
  • Growth Factors
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Chronic Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Other Chronic Wounds
• Acute Wounds
  • Surgical & Traumatic Wounds
  • Burns
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Specialty Clinics
• Home Healthcare
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Application Segment
  • 1.2.3. End Use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Advanced Wound Care Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
    • 3.2.1.2. Introduction of innovative and advanced wound products
    • 3.2.1.3. Rising geriatric population
    • 3.2.1.4. Increasing number of road accidents, trauma cases, and burns
    • 3.2.1.5. Increasing number of surgeries
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Delayed Diagnosis and lower treatment rates in emerging nations
• 3.3. Advanced Wound Care Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. Advanced Wound Care Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Advanced Wound Care Market Product Movement Analysis
• 4.3. Global Advanced Wound Care Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million)
• 4.4. Moist
  • 4.4.1. Moist market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.4.2. Foam Dressings
    • 4.4.2.1. Foam dressings market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.4.3. Hydrocolloid Dressings
    • 4.4.3.1. Hydrocolloid dressings market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.4.4. Film Dressings
    • 4.4.4.1. Film dressings market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.4.5. Alginate Dressings
    • 4.4.5.1. Alginate dressings market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.4.6. Hydrogel Dressings
    • 4.4.6.1. Hydrogel dressings market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.4.7. Collagen Dressings
    • 4.4.7.1. Collagen dressings market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.4.8. Other Advanced Dressings
    • 4.4.8.1. Other advanced dressings market estimates and forecasts 2021 - 2033 (USD Million)
• 4.5. Antimicrobial
  • 4.5.1. Antimicrobial market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.5.2. Silver
    • 4.5.2.1. Silver market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.5.3. Non-silver
    • 4.5.3.1. Non-silver market estimates and forecasts 2021 - 2033 (USD Million)
• 4.6. Active
  • 4.6.1. Active market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.6.2. Biomaterials
    • 4.6.2.1. Biomaterials market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.6.3. Skin-substitute
    • 4.6.3.1. Skin-substitute market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.6.4. Growth Factors
    • 4.6.4.1. Growth factors market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 5. Advanced Wound Care Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Advanced Wound Care Market Application Movement Analysis
• 5.3. Global Advanced Wound Care Market Size & Trend Analysis, by Application, 2021 - 2033 (USD Million)
• 5.4. Chronic Wounds
  • 5.4.1. Chronic wounds market estimates and forecasts 2021 - 2033 (USD Million)
  • 5.4.2. Diabetic Foot Ulcers
    • 5.4.2.1. Diabetic foot ulcers market estimates and forecasts 2021 - 2033 (USD Million)
  • 5.4.3. Pressure Ulcers
    • 5.4.3.1. Pressure ulcers market estimates and forecasts 2021 - 2033 (USD Million)
  • 5.4.4. Venous Leg Ulcers
    • 5.4.4.1. Venous leg ulcers market estimates and forecasts 2021 - 2033 (USD Million)
  • 5.4.5. Other Chronic Wounds
    • 5.4.5.1. Other chronic wounds market estimates and forecasts 2021 - 2033 (USD Million)
• 5.5. Acute Wounds
  • 5.5.1. Acute wounds market estimates and forecasts 2021 - 2033 (USD Million)
  • 5.5.2. Surgical & Traumatic Wounds
    • 5.5.2.1. Surgical & traumatic wounds market estimates and forecasts 2021 - 2033 (USD Million)
  • 5.5.3. Burns
    • 5.5.3.1. Burns market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 6. Advanced Wound Care Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Advanced Wound Care Market End Use Movement Analysis
• 6.3. Global Advanced Wound Care Market Size & Trend Analysis, by End Use, 2021 - 2033 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market estimates and forecasts 2021 - 2033 (USD Million)
• 6.5. Specialty Clinics
  • 6.5.1. Specialty clinics market estimates and forecasts 2021 - 2033 (USD Million)
• 6.6. Home Healthcare
  • 6.6.1. Home healthcare market estimates and forecasts 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Others market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 7. Advanced Wound Care Market: Regional Estimates & Trend Analysis By Product, Application, and End Use

• 7.1. Regional Market Share Analysis, 2025 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Market Size & Forecasts Trend Analysis, 2021 - 2033:
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Competitive scenario
    • 7.4.1.3. Regulatory framework
    • 7.4.1.4. Reimbursement scenario
    • 7.4.1.5. U.S. market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.4.2. Canada
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. Reimbursement scenario
    • 7.4.2.5. Canada market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.4.3. Mexico
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. Reimbursement scenario
    • 7.4.3.5. Mexico market estimates and forecasts 2021 - 2033 (USD Million)
• 7.5. Europe
  • 7.5.1. UK
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Competitive scenario
    • 7.5.1.3. Regulatory framework
    • 7.5.1.4. Reimbursement scenario
    • 7.5.1.5. UK market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. Germany market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.5.3. France
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. France market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.5.4. Italy
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Italy market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.5.5. Spain
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. Reimbursement scenario
    • 7.5.5.5. Spain market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.5.6. Norway
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Reimbursement scenario
    • 7.5.6.5. Norway market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Regulatory framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. Sweden market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Competitive scenario
    • 7.5.8.3. Regulatory framework
    • 7.5.8.4. Reimbursement scenario
    • 7.5.8.5. Denmark market estimates and forecasts 2021 - 2033 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Competitive scenario
    • 7.6.1.3. Regulatory framework
    • 7.6.1.4. Reimbursement scenario
    • 7.6.1.5. Japan market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. China market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.6.3. India
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. India market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.6.4. Australia
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. Australia market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Regulatory framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. South Korea market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Regulatory framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Thailand market estimates and forecasts 2021 - 2033 (USD Million)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement scenario
    • 7.7.1.5. Brazil market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.7.2. Argentina
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Argentina market estimates and forecasts 2021 - 2033 (USD Million)
• 7.8. MEA
  • 7.8.1. South Africa
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement scenario
    • 7.8.1.5. South Africa market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. Saudi Arabia market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.8.3. UAE
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive scenario
    • 7.8.3.3. Regulatory framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. UAE market estimates and forecasts 2021 - 2033 (USD Million)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Competitive scenario
    • 7.8.4.3. Regulatory framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. Kuwait market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2025
• 8.4. Company Profiles/Listing
  • 8.4.1. ConvaTec Group PLC
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Smith & Nephew PLC
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Molnlycke Health Care AB
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. B. Braun Melsungen AG
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. 3M
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. URGO
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Coloplast Corp.
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Integra LifeSciences
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Medline Industries, Inc.
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives